bioMérieux, Inc. Sponsored Cystic Fibrosis Webinar

May 29 | 2 PM ET | Trends in Bacterial Resistance and New Antibiotic Treatments for Acute Pulmonary Exacerbations in Patients with Cystic Fibrosis | Presented by: Joseph L. Kuti, PharmD, FIDP 



Chronic pulmonary infections in cystic fibrosis patients is an ongoing challenge. The emergence of multi-drug-resistant mucoid organisms, such as Pseudomonas aeruginosa, has further complicated these infections.



  • List problem bacterial pathogens in CF patients and other current resistance trends in this population
  • Describe challenges with microbiological identification and susceptibility testing of CF pathogens
  • Identify new antibiotics that may play a role in the treatment of acute pulmonary exacerbations in patients with CF


Professional Acknowledgment for Continuing Education (P.A.C.E.®) credits will be offered.





bioMérieux, Inc. is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. CE Broker in the state of Florida may not accept P.A.C.E. credits for this course. 

Pioneering Diagnostics